| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-11 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |